North America Lipidomics Equipment Market

The North America lipidomics equipment market is expected to grow from US$ 415.85 million in 2022 to US$ 943.65 million by 2028. It is estimated to register a CAGR of 14.6% from 2022 to 2028.      

Technological Advancements in Mass Spectrometry Fuels the North America Lipidomics Equipment Market

Mass spectrometers are commonly used for the identification and quantification of lipids. The high-energy collisional-activated dissociation (CAD) technique of mass spectrometry results in charge remote fragmentation (CRF) reactions, which help detect the location of small structural bond details. Several advanced mass spectrometers, including sector mass spectrometry, matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF), liquid chromatography-mass spectrometry (LC-MS), and tandem mass spectrometer have been made available for researchers and technicians. Further, these instruments are being integrated with automation, miniaturization, artificial intelligence (AI), and smart technologies to enhance their efficiencies and accuracies. In 2018, Thermo Scientific launched Genesys 50 UV/vis spectrometer that has a single-cell configuration for low sample throughput needs, with a removable, washable sampling compartment for easy clean-up. In the same year, Shimadzu, in collaboration with PREMIER Biosoft, launched Shimadzu's LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry (MS) system for lipidomics and glycomics data analysis. The product features informatics support powered by software solutions of PREMIER Biosoft. Therefore, the introduction of such new enhanced mass spectrometers and micropumps is boosting the growth of the North America lipidomics equipment market.     

North America Lipidomics Equipment Market Overview

The North America lipidomics equipment market has been segmented into the US, Canada, and Mexico. The US held the largest share of the North America lipidomics equipment market in 2022. The market growth in the country is primarily driven by the increasing prevalence of chronic diseases such as cancer. For instance, according to the National Cancer Institute, the country will see 1,735,350 new cancer cases in 2020. Breast cancer, lung and bronchus bronchial cancer, prostate cancer, colon and rectal cancer, melanoma cancer, and liver cancer are the most common types of cancer. The incidence rate of cancer is increasing at an alarming rate in the country, increasing the demand for cancer diagnoses. Increasing investments and rising funds dedicated to the pharma manufacturing companies and academic and research institutes for developing various medicines, the growing geriatric population, increasing incidence of infectious diseases, and other therapeutics are among the major driving factors. Additionally, most foreign companies in the healthcare sector have R&D centers in the United States. Because these facilities rely on lipidomics services to provide high-quality outcomes, this industry is projected to grow rapidly. Chronic illnesses account for seven out of ten fatalities in the United States. Currently, more than half of Americans live with a chronic illness. The incidence of these diseases is expected to reach 170 million in the United States by 2030, boosting the pharmaceutical industry and, in turn, the demand for lipidomics equipment in the country.

North America Lipidomics Equipment Market Revenue and Forecast to 2028 (US$ Million)

North America Lipidomics Equipment Strategic Insights

Strategic insights for the North America Lipidomics Equipment provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Lipidomics Equipment Report Scope

North America Lipidomics Equipment Regional Insights

The geographic scope of the North America Lipidomics Equipment refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

North America Lipidomics Equipment Market Segmentation    

The North America lipidomics equipment market is segmented based on type, offerings, services, end user, and country.

Based on type, the North America lipidomics equipment market is bifurcated into targeted and untargeted. The targeted segment held a larger market share in 2022.

Based on offerings, the North America lipidomics equipment market is segmented into MS-based lipidomics techniques, assays for lipid metabolism, lipid flux using heavy isotope-labeled precursors, software & services, and others. The MS-based lipidomics techniques segment held the largest market share in 2022. The MS-based lipidomics techniques segment is further categorized into mass spectrometers equipped with ion sources (turbo-) ESI/nano-ESI/APCI, autosamplers, micropumps, UV detectors, UPLC, variable-length fluorescence detectors, and others.  

Based on services, the North America lipidomics equipment market has been segmented into biomarker identification, bioinformatic analysis & data interpretation, molecular analysis of a broad spectrum of phospholipids (lipid fingerprinting), analysis & identification of unusual lipids, semiquantitative & quantitative analysis, lipid flux studies, and others. The biomarker identification segment held the largest market share in 2022.

Based on end user, the North America lipidomics equipment market is segmented into molecular research, cellular research, clinical research, tissue & organ research, data research, organism research, technical services & prototyping, production, and others. The molecular research segment held the largest market share in 2022.

Based on country, the North America lipidomics equipment market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US dominated the market in 2022.

Agilent Technologies, Inc.; Bruker; Cayman Chemical; Creative Proteomics; IonBench; Metabolon, Inc.; PerkinElmer Inc.; Sciex; Shimadzu Corporation.; and Thermo Fisher Scientific Inc. are among the leading companies operating in the North America lipidomics equipment market.